Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengning Zhang

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Endocrine|April 2, 2023
Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetesSuyan Duan, Meng Zhou, Fang Lu, et al.
Frontiers in Nutrition|May 14, 2023
Serum 25-hydroxyvitamin D as a predictive biomarker of clinical outcomes in patients with primary membranous nephropathySuyan Duan, Si Chen, Fang Lu, et al.
Diabetes & Metabolic Syndrome|May 14, 2024
25(OH)D level and vascular lesion scores in kidney histopathology as risk-stratification tool for predicting renal progression in people with type 2 diabetesSuyan Duan, Fang Lu, Rui Sun, et al.
Frontiers in Nutrition|August 18, 2025
Effect of time-weighted average 25(OH)D on the occurrence of major adverse kidney events in IgA nephropathy-from a 10-year population-based cohort studyFang Lu, Chang Liu, Dandan Song, et al.
Renal Failure|December 17, 2024
Delta corticomedullary apparent diffusion coefficient on MRI as a biomarker for prognosis in IgA nephropathyZitao Wang, Ling Jiang, Fang Lu, et al.
Diabetes & Metabolic Syndrome|February 19, 2024
Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetesSuyan Duan, Luhan Geng, Fang Lu, et al.
Kidney Diseases (Basel, Switzerland)|July 1, 2026
Association of Body Composition-Related Indicators with Urinary Protein Levels and Proteinuria Remission in Patients with Primary Membranous NephropathySimeng Liu, Yifei Lu, Si Chen, et al.
Frontiers in Immunology|October 3, 2025
B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of ChinaYili Xu, Liang Wang, Chunming Jiang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Endocrine|April 2, 2023
Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetesSuyan Duan, Meng Zhou, Fang Lu, et al.
Frontiers in Nutrition|May 14, 2023
Serum 25-hydroxyvitamin D as a predictive biomarker of clinical outcomes in patients with primary membranous nephropathySuyan Duan, Si Chen, Fang Lu, et al.
Diabetes & Metabolic Syndrome|May 14, 2024
25(OH)D level and vascular lesion scores in kidney histopathology as risk-stratification tool for predicting renal progression in people with type 2 diabetesSuyan Duan, Fang Lu, Rui Sun, et al.
Frontiers in Nutrition|August 18, 2025
Effect of time-weighted average 25(OH)D on the occurrence of major adverse kidney events in IgA nephropathy-from a 10-year population-based cohort studyFang Lu, Chang Liu, Dandan Song, et al.
Renal Failure|December 17, 2024
Delta corticomedullary apparent diffusion coefficient on MRI as a biomarker for prognosis in IgA nephropathyZitao Wang, Ling Jiang, Fang Lu, et al.
Diabetes & Metabolic Syndrome|February 19, 2024
Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetesSuyan Duan, Luhan Geng, Fang Lu, et al.
Kidney Diseases (Basel, Switzerland)|July 1, 2026
Association of Body Composition-Related Indicators with Urinary Protein Levels and Proteinuria Remission in Patients with Primary Membranous NephropathySimeng Liu, Yifei Lu, Si Chen, et al.
Frontiers in Immunology|October 3, 2025
B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of ChinaYili Xu, Liang Wang, Chunming Jiang, et al.
Pageof 4